CanaFarma Hemp Products Corp. (CNFHF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2020 | 2019 | 2018 |
|---|---|---|---|
| Revenue | 1.8 Million | 56.81 Thousand | - |
| Cost of Revenue | 4.12 Million | 87.84 Thousand | - |
| Gross Profit | -2.32 Million | -31.02 Thousand | - |
| Operating Expenses | 7.73 Million | 1.23 Million | 6964.92 |
| Selling, General and Administrative Expenses | 7.14 Million | 1.23 Million | 6964.92 |
| Research and Development Expenses | - | - | - |
| Other Expenses | - | - | - |
| Cost and Expenses | 11.86 Million | 1.32 Million | 6964.92 |
| Operating Income | -10.06 Million | -1.26 Million | -6963.40 |
| Interest Expense | - | - | - |
| Income Tax Expense | 25.00 | 25.32 | -161.14 Thousand |
| Earnings before Tax | -18.96 Million | -1.26 Million | -7012.05 |
| Net Income | -17.54 Million | -1.17 Million | -7012.05 |
| Earnings Per Share Basic | -0.12 | -0.01 | - |
| Earnings Per Share Diluted | -0.12 | -0.01 | - |
| Weighted Average Shares Outstanding | 152.39 Million | 187.31 Million | - |
| Weighted Average Shares Outstanding (Diluted) | 152.39 Million | 187.31 Million | - |
| Gross Margin | -1.29 | -0.55 | - |
| EBIT Margin | -5.54 | -21.65 | - |
| Profit Margin | -9.73 | -20.71 | - |
| EBITDA | -9.99 Million | -1.23 Million | -6963.40 |
| Earnings Before Tax Margin | -5.58 | -22.27 | - |
| Breakdown | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 FY | 2020 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 79.49 Thousand | 409.03 Thousand | 111.83 Thousand | -1.11 Million | 1.77 Million | 12.9 Thousand |
| Cost of Revenue | -18.82 Thousand | 603.55 Thousand | 1.26 Million | 2.92 Million | 3.47 Million | 2.45 Million |
| Gross Profit | 98.31 Thousand | -194.51 Thousand | -1.15 Million | -4.03 Million | -1.69 Million | -2.44 Million |
| Operating Expenses | 1.93 Million | 1.95 Million | 3.4 Million | 982.06 Thousand | 7.49 Million | 1.74 Million |
| Selling, General and Administrative Expenses | 1.93 Million | 1.91 Million | 3.36 Million | 959.93 Thousand | - | 1.71 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -4465.00 | 94.00 | -4743.00 | -20.8 Thousand | -20.93 Thousand | -130.00 |
| Cost and Expenses | 1.91 Million | 2.55 Million | 4.66 Million | 3.9 Million | 10.96 Million | 4.2 Million |
| Operating Income | -1.83 Million | -2.2 Million | -4.67 Million | -5.48 Million | -9.18 Million | -4.19 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 3.00 | -1.06 Million | -2.37 Million | 0.03 | 24.64 | 6.11 Million |
| Earnings before Tax | -819.76 Thousand | -1.08 Million | -2.18 Million | -7.25 Million | -18.69 Million | -11.3 Million |
| Net Income | -819.76 Thousand | -1.08 Million | -2.18 Million | -5.83 Million | -17.54 Million | -10.31 Million |
| Earnings Per Share Basic | -0.00 | -0.01 | -0.01 | -33.04 | - | -0.07 |
| Earnings Per Share Diluted | -0.00 | -0.01 | -0.01 | -33.04 | - | -0.07 |
| Weighted Average Shares Outstanding | 201.56 Million | 201.56 Million | 201.56 Million | 176.63 Thousand | 152.39 Million | 150.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 201.56 Million | 201.56 Million | 201.56 Million | 176.63 Thousand | 152.39 Million | 150.7 Million |
| Gross Margin | 1.24 | -0.48 | -10.30 | 3.63 | -0.95 | -189.55 |
| EBIT Margin | -22.42 | -7.65 | -61.28 | 2.49 | - | 233.14 |
| Profit Margin | -10.31 | -2.65 | -19.50 | 5.24 | -9.87 | -799.38 |
| EBITDA | -1.78 Million | -3.12 Million | -6.85 Million | -2.77 Million | - | 3 Million |
| Earnings Before Tax Margin | -23.10 | -5.39 | -41.84 | 4.93 | -5.17 | -325.20 |
VFS
RADIOCITY
VIDHIING
HAWEM
128820
002269